Search results
Results From The WOW.Com Content Network
U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country ...
Three dividend stocks that are cheap buys today, offer high yields, and could be good long-term plays include AstraZeneca (NASDAQ: AZN), ExxonMobil (NYSE: XOM), and Toronto-Dominion Bank (NYSE: TD).
AstraZeneca's stock fell by 3% last year and with its forward price-to-earnings (P/E) multiple at just 14, it could be a steal of a deal for investors right now.
In the latest trading session, Astrazeneca (AZN) closed at $55.69, marking a -0.75% move from the previous day. Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know Skip to main content
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [13]
Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease progression in patients with newly diagnosed ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In the latest trading session, Astrazeneca (AZN) closed at $50.56, marking a -0.59% move from the previous day.